Jesus Berdeja

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    BMS
    Topic: 
    Consultant
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Celgene
    Topic: 
    Consultant
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    CRISPR Therapeutics
    Topic: 
    Consultant
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Janssen
    Topic: 
    Consultant
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Kite Pharma
    Topic: 
    Consultant
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Legend Biotech
    Topic: 
    Consultant
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Roche
    Topic: 
    Consultant
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Takeda
    Topic: 
    Consultant
    Date added: 
    02/28/2023

Pages

Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice